Physician profile
Arooj Zarour
NPI 1609445147
$842.83
in general payments reported to CMS, 2019-2025
12 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $97.43 · 2023: $270 · 2024: $224 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.24 | 2024-2025 | |
| Amgen INC. | $128.73 | 2023 | Repatha |
| Penumbra, INC. | $124.99 | 2023 | Indigo System |
| Neurocrine Biosciences, INC. | $102.08 | 2021 | |
| Inari Medical, INC. | $99.66 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Otsuka America Pharmaceutical, INC. | $97.43 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $45.88 | 2025 | Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $25.22 | 2025 | |
| Exact Sciences Corporation | $23.25 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $19.77 | 2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.43 | 2025 | Xifaxan |
| Kaleo, INC. | $16.15 | 2023 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arooj Zarour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.